Correlation Between Crispr Therapeutics and Sana Biotechnology

Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crispr Therapeutics AG and Sana Biotechnology, you can compare the effects of market volatilities on Crispr Therapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Sana Biotechnology.

Diversification Opportunities for Crispr Therapeutics and Sana Biotechnology

0.97

Correlation Coefficient

Crispr Therapeutics  Sana Biotechnology

Almost no diversification

The 3 months correlation between Crispr and Sana is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Sana Biotechnology go up and down completely randomly.

Pair Corralation between Crispr Therapeutics and Sana Biotechnology

Given the investment horizon of 90 days Crispr Therapeutics is expected to generate 1.92 times less return on investment than Sana Biotechnology. But when comparing it to its historical volatility, Crispr Therapeutics AG is 1.6 times less risky than Sana Biotechnology. It trades about 0.17 of its potential returns per unit of risk. Sana Biotechnology is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  187.00  in Sana Biotechnology on May 5, 2025 and sell it today you would earn a total of  204.00  from holding Sana Biotechnology or generate 109.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Crispr Therapeutics AG  vs.  Sana Biotechnology

Crispr Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Crispr Therapeutics AG are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Crispr Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Sana Biotechnology

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Crispr Therapeutics and Sana Biotechnology

The main advantage of trading using opposite Crispr Therapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.

The idea behind Crispr Therapeutics AG and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.